(Q46917778)

26 December 2017

title

Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism (English)

1 reference

26 December 2017

author name string

Nils Kucher

1

1 reference

26 December 2017

Rene Quiroz

2

1 reference

26 December 2017

Sylvia McKean

3

1 reference

26 December 2017

Arthur A Sasahara

4

1 reference

26 December 2017

Samuel Z Goldhaber

5

1 reference

26 December 2017

publication date

1 November 2005

1 reference

26 December 2017

published in

Vascular Medicine

1 reference

26 December 2017

volume

10

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

page(s)

251-256

1 reference

26 December 2017

Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM634OA

Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM634OA

Major bleeding after hospitalization for deep-venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM634OA

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM634OA

Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM634OA

Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM634OA

Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM634OA

Prognostic Role of Brain Natriuretic Peptide in Acute Pulmonary Embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM634OA

Acute pulmonary embolism: part II: risk stratification, treatment, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM634OA

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM634OA

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM634OA

Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM634OA

Is laboratory monitoring of low-molecular-weight heparin therapy necessary? Yes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM634OA

Is laboratory monitoring of low-molecular-weight heparin therapy necessary? No.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM634OA

10.1191/1358863X05VM634OA

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017